Nurix Therapeutics NRIX
$12.85 −$0.75 (-5.51%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.85 0.00%
Open$13.40
Prev close$13.60
Day range$12.83 – $13.67
Volume2.43M
Market cap$1.40B
P/E (TTM)5.3
Dividend yield–
Analyst view
ConsensusBuy
Analysts9
Average target$35.33+174.9% vs. price
- Buy 100%
Low $32.00Now $12.85Avg $35.33High $41.00
Recent rating changes
The last 20 actions on file set price targets from $25.00 to $41.00, averaging $35.05.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Nov 2026 | H.C. Wainwright | BUY | $36.00 |
| 5 Nov 2026 | RBC Capital | BUY | $35.00 |
| 4 Nov 2026 | Stifel | BUY | $41.00 |
| 3 Nov 2026 | BTIG | BUY | $32.00 |
| 2 Nov 2026 | Piper Sandler | BUY | $35.00 |
| 16 Oct 2026 | H.C. Wainwright | BUY | $36.00 |
| 15 Oct 2026 | Morgan Stanley | BUY | $38.00 |
| 13 Oct 2026 | Piper Sandler | BUY | $35.00 |
| 13 Oct 2026 | Truist Financial | BUY | $33.00 |
| 13 Oct 2026 | Baird | BUY | $36.00 |
| 13 Oct 2026 | Stifel | BUY | $41.00 |
| 13 Oct 2026 | Oppenheimer | BUY | $32.00 |
| 12 Oct 2026 | RBC Capital | BUY | $35.00 |
| 10 Aug 2026 | RBC Capital | BUY | $36.00 |
| 4 Aug 2026 | Needham | BUY | $34.00 |
| 28 Jul 2026 | Morgan Stanley | BUY | $38.00 |
| 27 Jul 2026 | Morgan Stanley | BUY | $38.00 |
| 22 Jul 2026 | UBS | BUY | $31.00 |
| 14 Jul 2026 | Wells Fargo | HOLD | $25.00 |
| 10 Jul 2026 | H.C. Wainwright | BUY | $34.00 |
No comments yet — be the first to weigh in on NRIX.
Sign in to join the discussion.